Minnesota Living With Heart Failure Questionnaire

The minnesota living with heart failure questionnaire lhfq is a commonly used measure of health related quality of life in persons with heart failure researchers have questioned whether lhfq is sensitive to subtle differences and sufficiently responsive to clinical interventions because the instrument has demonstrated variable performance in clinical trials.

Minnesota living with heart failure questionnaire.

The united states food drug administration fda has approved the minnesota living with heart failure questionnaire mlhfq as a medical device development tool mddt for use in controlled clinical trials designed to test superiority or non inferiority of medical devices in support of regulatory submissions. The minnesota living with heart failure questionnaire mlwhfq which is today largely used worldwide is a specific questionnaire for the assessment of qol in hf patients that was introduced by rector et al in 1987. The minnesota living with heart failure questionnaire mlhfq is a reliable and valid patient oriented measure of the adverse effects of heart failure on a patient s life. The university of.

Kansas city cardiomyopathy questionnaire recommendations on the basis of appraisal of evidence by the prom group and taking account of ratings and comments from the panel the sf 36 and eq 5d are considered suitable as generic measures in heart failure. Half of the 21 item minnesota living with heart failure questionnaire mlhfq response categories are labeled 0 no 1 very little 5 very much and half are not 2 3 and 4. The minnesota living with heart failure questionnaire mlhfq is one of the most widely used health related quality of life questionnaires for patients with heart failure hf. However this questionnaire has not been translated and validated in albanian language.

Minnesota living with heart failure questionnaire 5. Patients self assessment of their congestive heart failure. The united states food and drug administration fda has approved the minnesota living with heart failure questionnaire as medical device development tool mddt for use in controlled clinical trials designed to test. It provides scores for two dimensions physical and emotional and a total score.

However there are some concerns about its factor structure and alternatives have been proposed some including a third factor.